Bring Your Biotech to Europe and the UK with Confidence
Integrated regulatory, quality, and operational expertise to turn US progress into European market readiness
European expansion requires more than extending an FDA pathway. We help you translate US development momentum into a compliant, strategically aligned, and executable EU and UK entry plan.
Through our end-to-end European market entry expertise, we help you translate FDA-driven clinical and regulatory momentum into a structured, compliant, and achievable EU/UK expansion plan, execute regulatory submissions and interactions with EU and UK authorities, and implement quality and safety systems necessary to operate seamlessly in the market.
Our integrated approach ensures that your European expansion is not only feasible but strategically aligned and operationally ready.
End-to-End Support for EU & UK Market Entry
Successfully entering the EU and UK markets requires coordinated planning across regulatory, quality, and operational functions from the outset. While US companies often have strong development foundations, European requirements introduce additional layers of procedural, compliance, and structural considerations that influence feasibility, timelines, and execution.
Key challenges we address
Divergent Regulatory Pathways
EU and UK regulatory frameworks follow different procedural logics, review timelines, and authority interactions than the US.
FDA Documentation Adaptation
US-focused clinical and regulatory documentation often needs structural and strategic modifications to meet EU/UK scientific and procedural expectations.
Extended Compliance Requirements
Obligations start earlier and continue beyond approval, including pharmacovigilance, QA oversight, and MAH responsibilities.
Fragmented Support Across Functions
Siloed RA, QA, QP, PV, and MAH support increases coordination effort and execution risk.
Limited Local Infrastructure
Authority interactions, submissions, and operational readiness can be harder to control without established European infrastructure.
A Structured, Scalable Pathway from US Readiness to EU and UK Market Entry
We guide US companies through every stage of European expansion with a clear, phased approach that aligns strategy, regulatory execution, and operational readiness.
Align on the EU and UK Development Path
We clarify your product ambition, target markets, and clinical milestones to create a practical EU and UK roadmap grounded in European realities.
Identify Gaps and Priority Actions
Through a focused assessment, we pinpoint gaps between US and EU requirements across strategy, evidence, CMC, quality, and safety, producing a prioritized plan with realistic timelines.
Build Foundations and Execute Critical Workstreams
QbD Group coordinates regulatory submissions, GMP readiness, and procedural governance, ensuring EU and UK milestones progress predictably.
Scale Support as EU and UK Activities Grow
As your program evolves, our support scales with you, providing additional expertise when needed without requiring premature EU infrastructure.
Clarity, Control, and Confidence in European Expansion
Expanding into Europe requires more than regulatory approval. It demands structure, alignment, and operational control.
What you gain
Structured EU and UK Pathway
A practical, phased approach that translates US regulatory foundations into EU- and UK-ready development and submission plans.
Optimized Documentation Transition
Strategic conversion of FDA-focused documentation into EU- and UK-ready submission content, reducing rework and avoiding unnecessary delays.
Coordinated Regulatory Management
Structured handling of submissions and authority interactions across EU and UK systems to maintain momentum and procedural clarity.
Sustainable Operational Readiness
Implementation of PV, QA oversight, and MAH frameworks to enable compliant, stable, and long-term European operations.
Integrated Cross-Functional Delivery
Unified management of strategy, regulatory execution, quality, and safety to reduce fragmentation and lower expansion risk.
Why QbD Group
One integrated partner for your entire European expansion — from strategy and submissions to quality, safety, and market operations.
Integrated European expertise
across regulatory, quality, QP, PV, and MAH, reducing fragmentation during EU and UK expansion.
Hands-on experience navigating European procedures and authorities
, grounded in practical execution, not just regulatory theory.
Execution-driven support combining strategy and delivery
, ensuring submissions, systems, and governance move forward together.
A scalable partnership model for US companies entering Europe
, providing early structure while supporting long-term market presence.
FAQ
Frequently asked questions
Ready to bring your biotech to Europe?
Partner with QbD Group to accelerate your US company's entry into Europe and the UK.